35094 Federal Register / Vol. 86, No. 124 / Thursday, July 1, 2021 / Notices 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–14007 Filed 6–30–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Healthcare Infection Control Practices 

Advisory Committee (HICPAC) Meeting 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

CDC announces the following meeting 

for the Healthcare Infection Control 

Practices Advisory Committee 

(HICPAC). This virtual meeting is open 

to the public, limited only by audio and 

web conference lines (300 audio and 

web conference lines are available). 

Registration is required. To register for 

this web conference, please go to: 

www.cdc.gov/hicpac. All registered 

participants will receive the meeting 

link and instructions shortly before the 

meeting. 

DATES: The meeting will be held on 

August 19, 2021, from 12:00 p.m. to 2:00 

p.m., EDT. 

ADDRESSES: Please click the link below 

to join the webinar: https://

cdc.zoomgov.com/j/1612908106?

pwd=M0xTVWxmUTRtZXhu

OVBzWmsybFZxZz09. 

Meeting ID: 161 290 8106 

Passcode: yq!BLL44 

Dial-in Lines: 

+1–669–254–5252 (San Jose) 

+1–646–828–7666 (New York) 

Meeting ID: 161 290 8106 

Telephone Passcode: 47632330. 

FOR FURTHER INFORMATION CONTACT: KooWhang Chung, M.P.H., HICPAC, 

Division of Healthcare Quality 

Promotion, NCEZID, CDC, 1600 Clifton 

Road NE, Mailstop H16–3, Atlanta, 

Georgia 30329–4027; Telephone: (404) 

498–0730; Email: HICPAC@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Purpose: The Committee is charged 

with providing advice and guidance to 

the Director, Division of Healthcare 

Quality Promotion (DHQP), the Director, 

National Center for Emerging and 

Zoonotic Infectious Diseases (NCEZID), 

the Director, CDC, the Secretary, Health 

and Human Services regarding (1) the 

practice of healthcare infection 

prevention and control; (2) strategies for 

surveillance, prevention, and control of 

infections, antimicrobial resistance, and 

related events in settings where 

healthcare is provided; and (3) periodic 

updating of CDC guidelines and other 

policy statements regarding prevention 

of healthcare-associated infections and 

healthcare-related conditions. 

Matters To Be Considered: The agenda 

will include the following updates: The 

Healthcare Personnel Guideline 

Workgroup; the Isolation Precautions 

Guideline Workgroup; and the Neonatal 

Intensive Care Unit Workgroup. Agenda 

items are subject to change as priorities 

dictate. 

Procedures for Public Comment: Time 

will be available for public comment. 

Members of the public who wish to 

provide public comments should plan 

to attend the public comment session at 

the start time listed. Please note that the 

public comment period may end before 

the time indicated, following the last 

call for comments. 

Procedures for Written Comment: The 

public may submit written comments in 

advance of the meeting. Comments 

should be submitted in writing by email 

to the contact person listed above. The 

deadline for receipt of written public 

comment is July 26, 2021. All requests 

must contain the name, address, and 

organizational affiliation of the speaker, 

as well as the topic being addressed. 

Written comments should not exceed 

one single-spaced typed page in length. 

Written comments received in advance 

of the meeting will be included in the 

official record of the meeting. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–14008 Filed 6–30–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–10516] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, and to allow 

a second opportunity for public 

comment on the notice. Interested 

persons are invited to send comments 

regarding the burden estimate or any 

other aspect of this collection of 

information, including the necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions, the accuracy of 

the estimated burden, ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and the use 

of automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

DATES: Comments on the collection(s) of 

information must be received by the 

OMB desk officer by August 2, 2021. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following: 

1. Access CMS’ website address at: 

https://www.cms.gov/Regulations-andGuidance/Legislation/Paperwork

ReductionActof1995/PRA-Listing.html 

FOR FURTHER INFORMATION CONTACT: 

William Parham at (410) 786–4669. 


khammond on DSKJM1Z7X2PROD with NOTICES